Toronto, ON, Dec.6, 2023: Medical technology innovator Thornhill Medical is pleased to announce that the United States Marine Corps (USMC) has acquired its integrated life support technology, MOVES® SLC™. The acquisition supports USMC En Route Care modernization goals using state-of-the-art, lightweight, critical care equipment to successfully transport patients from Role 2 to Role 3 care. MOVES® SLC™ has also been formally added to the U.S. Marine Corps’ Authorized Medical Allowance List (AMAL) 647 for En Route Care.
The game-changing MOVES® SLC™ system addresses the need for medical technology that is smaller, lighter, more durable, flexible and easy to maintain, and less reliant on supply chain. This enables care of wounded Marines with advanced critical care capabilities in far forward, extreme or austere environments, sustaining care over lengthy evacuation distances, with a variety of transportation modes.
MOVES® SLC™ is the only micro-integrated life support system that combines an oxygen (O2) concentrator, a unique O2-conserving ventilator, suction, and complete vital signs monitoring in a single compact, rugged, portable, battery-operated system, which operates without oxygen cylinders.
Thornhill Medical’s first generation of MOVES® technology was developed specifically for the needs of the USMC. Since that time, the transformative technology has been making a remarkable impact in the delivery of care and transport of trauma patients in current real-world combat and humanitarian missions.
“Mobility and logistic efficiency will overwhelmingly influence the ability of military medicine to accomplish its mission and save lives,” explains Thornhill Medical Military Advisory Council Member and former US Navy Surgeon General, VADM (Dr.) Forrest Faison (US Navy, Ret) “Innovative medical technologies built for battlefields like Thornhill Medical’s MOVES® SLC™ delivers on both mobility and reducing logistic support requirements to allow medical teams to deliver the latest and best technologies for casualty care anywhere, at any time, and to sustain that capability throughout the conflict.”
About Thornhill Medical
A global innovator in respiratory and oxygen-related scientific research and advanced technologies, Thornhill Medical is transforming the delivery of critical care in austere and unpredictable combat casualty care and humanitarian environments. Its flagship micro-integrated life support system with built-in oxygen supply, MOVES® SLC™, and its companion anesthesia solution, MADM™, are solving critical care capabilities gaps to save lives. Drawing on 20 years of pioneering scientific and engineering innovations that address the needs of health systems and providers, Thornhill Medical is unlocking tomorrow’s medical technology solutions, today. The team is pushing the boundaries of what’s technologically possible in interoperability, remote or autonomous delivery and the use of AI, and is developing solutions that can transform vascular diagnostics through arterial blood gas control. Thornhill Medical collaborates each day with customers, innovation leaders, industry, hospital, and military partners in more than 19 countries and in 65+ research institutes.
Learn more: https://thornhillmedical.com
For more information, please contact: